Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Articles

Wortmannin, a Potent and Selective Inhibitor of Phosphatidylinositol-3-kinase

Garth Powis, Rosanne Bonjouklian, Margareta M. Berggren, Alfred Gallegos, Robert Abraham, Curtis Ashendel, Leon Zalkow, William F. Matter, Jeffrey Dodge, Gerald Grindey and Chris J. Vlahos
Garth Powis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosanne Bonjouklian
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margareta M. Berggren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfred Gallegos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Abraham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Curtis Ashendel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leon Zalkow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William F. Matter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey Dodge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerald Grindey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris J. Vlahos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 1994
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Phosphatidylinositol-3-kinase is an important enzyme for intracellular signaling. The microbial product worthmannin and some of its analogues have been shown to be potent inhibitors of phosphatidylinositol-3-kinase. The 50% inhibitory concentration for inhibition by wortmannin is 2 to 4 nm. Kinetic analysis demonstrates that wortmannin is a noncompetitive, irreversible inhibitor of phosphatidylinositol-3-kinase, with inactivation being both time- and concentration-dependent. Wortmannin has previously been reported to be an inhibitor of myosin light chain kinase but with an inhibitory concentration of 0.2 µm. Wortmannin was found not to be an inhibitor of phosphatidylinositol-4-kinase, protein kinase C, or protein tyrosine kinase. Wortmannin inhibited the formation of phosphatidylinositol-3-phosphates in intact cells. The results of the study suggest that wortmannin and its analogues may have utility as pharmacological probes for studying the actions of phosphatidylinositol-3-kinase.

Footnotes

  • ↵1 Work in the laboratories of G.P., R.A., C.A. and L.Z. supported by NCI Grant CA52995.

  • ↵2 To whom requests for reprints should be addressed, at Arizona Cancer Center, University of Arizona, 1515 North Campbell Avenue, Tucson, AZ 85724

  • Received December 3, 1993.
  • Accepted February 28, 1994.
  • ©1994 American Association for Cancer Research.
PreviousNext
Back to top
May 1994
Volume 54, Issue 9
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Wortmannin, a Potent and Selective Inhibitor of Phosphatidylinositol-3-kinase
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Wortmannin, a Potent and Selective Inhibitor of Phosphatidylinositol-3-kinase
Garth Powis, Rosanne Bonjouklian, Margareta M. Berggren, Alfred Gallegos, Robert Abraham, Curtis Ashendel, Leon Zalkow, William F. Matter, Jeffrey Dodge, Gerald Grindey and Chris J. Vlahos
Cancer Res May 1 1994 (54) (9) 2419-2423;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Wortmannin, a Potent and Selective Inhibitor of Phosphatidylinositol-3-kinase
Garth Powis, Rosanne Bonjouklian, Margareta M. Berggren, Alfred Gallegos, Robert Abraham, Curtis Ashendel, Leon Zalkow, William F. Matter, Jeffrey Dodge, Gerald Grindey and Chris J. Vlahos
Cancer Res May 1 1994 (54) (9) 2419-2423;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Intersections between Blood Cell Development and Leukemia Genes
  • Genetic Control of Programmed Cell Death in the Nematode Caenorhabditis elegans
  • The Prizes
Show more Regular Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement